{"organizations": [], "uuid": "f248e343f2ab58c6e8360451f75dcc31704bc097", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180121.html", "section_title": "Archive News &amp; Video for Sunday, 21 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-symbio-pharmaceuticals-initiated-p/brief-symbio-pharmaceuticals-initiated-phase-1-study-in-japan-for-oral-treakisym-in-patients-with-progressive-solid-tumors-idUSFWN1PE1CO", "country": "US", "domain_rank": 408, "title": "BRIEF-Symbio Pharmaceuticals ‍initiated Phase 1 Study in Japan for Oral Treakisym in patients with progressive solid tumors​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.976, "site_type": "news", "published": "2018-01-22T07:35:00.000+02:00", "replies_count": 0, "uuid": "f248e343f2ab58c6e8360451f75dcc31704bc097"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-symbio-pharmaceuticals-initiated-p/brief-symbio-pharmaceuticals-initiated-phase-1-study-in-japan-for-oral-treakisym-in-patients-with-progressive-solid-tumors-idUSFWN1PE1CO", "ord_in_thread": 0, "title": "BRIEF-Symbio Pharmaceuticals ‍initiated Phase 1 Study in Japan for Oral Treakisym in patients with progressive solid tumors​", "locations": [], "entities": {"persons": [], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "brief-symbio pharmaceuticals", "sentiment": "negative"}, {"name": "reuters) - symbio pharmaceuticals ltd", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 21 (Reuters) - Symbio Pharmaceuticals Ltd:\n* ‍HAS INITIATED A PHASE 1 STUDY IN JAPAN FOR ORAL TREAKISYM IN PATIENTS WITH PROGRESSIVE SOLID TUMORS​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-22T07:35:00.000+02:00", "crawled": "2018-01-22T20:41:52.024+02:00", "highlightTitle": ""}